Intranasal administration of let-7 mimics reduced IL-13 levels in allergic lungs and alleviated asthma features, such as airway hyper responsiveness, airway inflammation, and goblet cell metaplasia (Kumar et al., 2011). Here, IL13 is linked to asthma.